“Combination therapy should be considered the standard treatment in patients with Alzheimers disease”.
Combination therapy should be considered the standard treatment in patients with Alzheimer’s disease ”. XVII national course of Alzheimer’s disease. -the 17TH course national Alzheimer’s disease ended Saturday in Cádiz after three intense days of work with important conclusions for the medical community regarding the diagnosis and treatment of this pathology, both pharmacological and cognitive stimulation through – in addition, 200 experts registered in the course has expanded its training through participation in workshops, notably the one dedicated to the neuropsychological scales in the dementia consultation Cadiz, February of 2012- the 17TH Edition of the national course of Alzheimer’s disease, which was held in the Palace of congresses of Cádiz on Thursday and has been organised by the Fundación Grünenthal in conjunction with the conduct group of the study of Neurology and dementia from the Spanish Neurology Society (SEN), has been completed with important conclusions for the medical community (specialists in neurology, geriatrics, psychiatry, primary care physicians)(, etc.), both with regard to diagnosis and treatment of this pathology. at the present time, there are two types of drugs available for the treatment of Alzheimer’s disease, inhibitors of acetylcholinesterase (Donepezil, rivastigmine and galantamine) and memantine ”, explained in one of the round tables Dr. Adrián Ares Luque, complex healthcare University of León, who added that all of them have proved their effectiveness in the control of cognitive disorders, behavioral and...
Read More